LINNIK MATTHEW D 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Dec 27, 2006
Insider Transaction Report
Form 4
LINNIK MATTHEW D
CSO & Exec VP of Research
Transactions
- Sale
Common Stock
2006-12-21$2.88/sh−5,000$14,394→ 1,665 total - Sale
Common Stock
2006-12-27$3.03/sh−365$1,106→ 1,300 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated as of November 1, 2006.